3 ms·
This one is the most recent one: https://www.polsinelli.com/publications/federal-circuit-clarifies-rules-for-skinny-labeling-for-generics-and-biosimilar-compani
by cyberax 10mo ago
This one is the most recent one:
https://www.polsinelli.com/publications/federal-circuit-clarifies-rules-for-skinny-labeling-for-generics-and-biosimilar-companies https://www.polsinelli.com/publications/federal-circuit-clar... There was also GSK vs Teva case.
- nkmnz 10mo agoThank you! The technical term seems to be Second Medical Use patent. > industry that takes existing drugs that are widely used off-label and patents that off-label use I wonder why "wide off-lable use" shouldn't be considered prior art?